Denise Kruzikas

689 total citations
24 papers, 524 citations indexed

About

Denise Kruzikas is a scholar working on Epidemiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Denise Kruzikas has authored 24 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Denise Kruzikas's work include Cervical Cancer and HPV Research (6 papers), Global Cancer Incidence and Screening (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Denise Kruzikas is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Global Cancer Incidence and Screening (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Denise Kruzikas collaborates with scholars based in United States, United Kingdom and Spain. Denise Kruzikas's co-authors include Trent P. McLaughlin, Rezaul Karim Khandker, Sissi V. Pham, Raj Tummala, Jennifer S. Smith, Mitchell K. Higashi, Didier Allexandre, Emily Fox, Pat Ray Reese and Alex Z. Fu and has published in prestigious journals such as Stroke, Annals of the Rheumatic Diseases and The Journal of Pediatrics.

In The Last Decade

Denise Kruzikas

22 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Kruzikas United States 12 139 138 87 86 64 24 524
Helen Coelho United Kingdom 12 43 0.3× 186 1.3× 75 0.9× 24 0.3× 125 2.0× 22 771
Greer A. Raggio United States 15 53 0.4× 185 1.3× 53 0.6× 20 0.2× 21 0.3× 25 652
Mengting Zhu China 13 42 0.3× 160 1.2× 49 0.6× 18 0.2× 51 0.8× 24 532
Jonas Bromberg United States 13 102 0.7× 105 0.8× 78 0.9× 31 0.4× 13 0.2× 18 703
Richard V. Weiss United States 6 385 2.8× 89 0.6× 42 0.5× 29 0.3× 35 0.5× 8 817
Abedin Iranpour Iran 14 160 1.2× 82 0.6× 33 0.4× 38 0.4× 10 0.2× 77 602
Eva Münster Germany 11 88 0.6× 78 0.6× 39 0.4× 87 1.0× 12 0.2× 32 533
Atefeh Noori Iran 12 223 1.6× 89 0.6× 52 0.6× 99 1.2× 9 0.1× 34 649
Walter J. Jones United States 12 70 0.5× 93 0.7× 37 0.4× 50 0.6× 20 0.3× 35 508
Magdalena Harrington United States 15 293 2.1× 100 0.7× 24 0.3× 35 0.4× 9 0.1× 32 769

Countries citing papers authored by Denise Kruzikas

Since Specialization
Citations

This map shows the geographic impact of Denise Kruzikas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Kruzikas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Kruzikas more than expected).

Fields of papers citing papers by Denise Kruzikas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Kruzikas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Kruzikas. The network helps show where Denise Kruzikas may publish in the future.

Co-authorship network of co-authors of Denise Kruzikas

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Kruzikas. A scholar is included among the top collaborators of Denise Kruzikas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Kruzikas. Denise Kruzikas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Spiera, Robert, Valérie Devauchelle‐Pensec, Claire Owen, et al.. (2025). Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis & Rheumatology. 77(8). 1041–1051. 2 indexed citations
3.
4.
Deodhar, Atul, et al.. (2021). Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study. Rheumatology and Therapy. 9(2). 447–463. 9 indexed citations
5.
Kruzikas, Denise, et al.. (2020). HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications. Journal of Managed Care & Specialty Pharmacy. 26(12). 1548–1557. 2 indexed citations
6.
Kruzikas, Denise, et al.. (2014). Using Agent-Based Modeling to Inform Regional Health Care System Investment and Planning. 211–214. 7 indexed citations
7.
8.
Allexandre, Didier, Emily Fox, Alex Z. Fu, et al.. (2013). Feasibility of an Online Mindfulness Program for Stress Management—A Randomized, Controlled Trial. Annals of Behavioral Medicine. 46(2). 137–148. 121 indexed citations
9.
Rymer, Marilyn M., et al.. (2013). Analysis of the Costs and Payments of a Coordinated Stroke Center and Regional Stroke Network. Stroke. 44(8). 2254–2259. 5 indexed citations
10.
Kruzikas, Denise, et al.. (2012). Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions. Cancer Epidemiology Biomarkers & Prevention. 21(9). 1469–1478. 11 indexed citations
11.
Taylor, Douglas C.A., et al.. (2011). Incorporating Calibrated Model Parameters into Sensitivity Analyses. PharmacoEconomics. 30(2). 119–126. 19 indexed citations
12.
Taylor, Douglas C.A., et al.. (2011). Calibrating Longitudinal Models to Cross-Sectional Data: The Effect of Temporal Changes in Health Practices. Value in Health. 14(5). 700–704. 6 indexed citations
13.
Taylor, Douglas C.A., et al.. (2010). Methods of Model Calibration. PharmacoEconomics. 28(11). 995–1000. 24 indexed citations
14.
Lerner, Debra, Susan K. Parsons, David Chelmow, et al.. (2010). The Impact of Precancerous Cervical Lesions on Functioning at Work and Work Productivity. Journal of Occupational and Environmental Medicine. 52(9). 926–933. 8 indexed citations
15.
Ting, Jie, Denise Kruzikas, & Jennifer S. Smith. (2010). A Global Review of Age-Specific and Overall Prevalence of Cervical Lesions. International Journal of Gynecological Cancer. 20(7). 1244–1249. 44 indexed citations
16.
Happe, Laura E., Orsolya Lunacsek, Denise Kruzikas, & Gary S. Marshall. (2009). Impact of a Pentavalent Combination Vaccine on Immunization Timeliness in a State Medicaid Population. The Pediatric Infectious Disease Journal. 28(2). 98–101. 34 indexed citations
17.
Khandker, Rezaul Karim, Denise Kruzikas, & Trent P. McLaughlin. (2008). Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder. Journal of Managed Care Pharmacy. 14(5). 426–441. 18 indexed citations
18.
Stempel, David A., Denise Kruzikas, & Ranjani Manjunath. (2007). Comparative Efficacy and Cost of Asthma Care in Children with Asthma Treated with Fluticasone Propionate and Montelukast. The Journal of Pediatrics. 150(2). 162–167. 17 indexed citations
19.
Goldstein, Jay L., et al.. (2006). Impact of Adherence to Concomitant Gastroprotective Therapy on Nonsteroidal-Related Gastroduodenal Ulcer Complications. Clinical Gastroenterology and Hepatology. 4(11). 1337–1345.e1. 72 indexed citations
20.
McLaughlin, Trent P., Rezaul Karim Khandker, Denise Kruzikas, & Raj Tummala. (2006). Overlap of Anxiety and Depression in a Managed Care Population. The Journal of Clinical Psychiatry. 67(8). 1187–1193. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Coelho Breakdown of academic impact, for papers by Greer A. Raggio Breakdown of academic impact, for papers by Mengting Zhu Breakdown of academic impact, for papers by Jonas Bromberg Breakdown of academic impact, for papers by Richard V. Weiss Breakdown of academic impact, for papers by Abedin Iranpour Breakdown of academic impact, for papers by Eva Münster Breakdown of academic impact, for papers by Atefeh Noori Breakdown of academic impact, for papers by Walter J. Jones Breakdown of academic impact, for papers by Magdalena Harrington
Rankless by CCL
2026